Evidence map›Paper›PMID 42169124›Full record

ReviewJournal of neuroinflammation2026

Liver-nervous system axis: pathways, dysregulation, and translational perspectives.

Donglin Hao, Yuebo Hu, Wei Luo, Shihui Li, Yongmin Yan, Jing Zhou

Abstract readReview
In one paragraph

Review in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Donglin Hao *Department of Laboratory Medicine, Wujin Hospital Affiliated With Jiangsu University, Jiangsu University, Changzhou, 213017, China.
Yuebo Hu *Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Neuroregeneration of Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, China.
Wei LuoDepartment of Laboratory Medicine, Wujin Hospital Affiliated With Jiangsu University, Jiangsu University, Changzhou, 213017, China.
Shihui LiDepartment of Laboratory Medicine, Wujin Hospital Affiliated With Jiangsu University, Jiangsu University, Changzhou, 213017, China.
Yongmin YanDepartment of Laboratory Medicine, Wujin Hospital Affiliated With Jiangsu University, Jiangsu University, Changzhou, 213017, China. yym@wjrmyy.cn.
Jing ZhouDepartment of Laboratory Medicine, Wujin Hospital Affiliated With Jiangsu University, Jiangsu University, Changzhou, 213017, China. zj_wjlab@163.com.

Funding

Changzhou's 14th five-year plan project to train high-level health professionals 2022CZLJ027Medical Research Project of Jiangsu Health Commission ZQ2025032National Natural Science Foundation of China 82272421Open project of Jiangsu Provincial Key Laboratory of Key Laboratory of Laboratory Medicine JSKLM-T-2025-01Open project of Jiangsu Provincial Key Laboratory of Key Laboratory of Laboratory Medicine JSKLM-Y-2024-005Open project of Jiangsu Provincial Key Laboratory of Key Laboratory of Laboratory Medicine JSKLM-Z-2025-01Scientific Research Project of Jiangsu Commission of Health K2024037
6 · The paper itself

Abstract

The liver and the nervous system form a dynamic bidirectional regulatory network through the liver-nervous system axis, which is crucial for maintaining metabolic homeostasis, immune balance, and the integrity of neural function in the body. However, the specific regulatory pathways between the liver and the nervous system, as well as their mechanisms in the development and progression of diseases, remain incompletely understood. Moreover, the dynamic regulatory mechanisms of the blood-brain barrier in the transport of liver metabolites are yet to be elucidated. Therefore, we have integrated the latest research advances in recent years in the fields of liver innervation, the neuroregulatory effects of liver-derived substances, and the trans-organ conduction of inflammatory mediators. Additionally, we incorporate clinical translational evidence from the application of β-blockers, vagus nerve stimulation, liver transplantation, and other interventions to systematically elucidate the coordinated regulatory patterns of the liver and the nervous system under physiological conditions, as well as the mechanisms of interactive disorders under pathological conditions. The aim is to clarify the interactions between the liver and the nervous system and their significance in physiological and pathological processes, thus providing a theoretical basis and potential therapeutic targets for future related research.

Indexed as

LiverLiver DiseasesNervous SystemAnimalsBlood-Brain BarrierHumansBlood–brain barrierHepatic encephalopathyLiverLiver-nervous system axisNervous systemNeuroinflammation

Identifiers

PMID42169124
PMCPMC13371456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.